Key Segmentation
By Product
-
Single-Cell Genomics
-
Single-Cell Proteomics
-
Single-Cell Metabolomics
-
Single-Cell Transcriptomics
By Application
-
Immunology
-
Cell Biology
-
Oncology
-
Neurology
By End-user
-
Hospital and Diagnostic Laboratories
-
Academic and Research Organizations
-
Pharmaceutical & Biotechnology Companies
-
Others
By Technology Platform
-
Droplet-based Microfluidics
-
Nanowell / Combinatorial Indexing
-
Spatial-omics Platforms
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
The single-cell multiomics market is expected to grow at a CAGR of 19.81% from 2026 to 2035.
The single-cell multiomics market was valued at USD 2.99 billion in 2025.
The Major growth factors include precision medicine adoption, high-resolution cellular analysis demand, expanding biotech R&D, oncology and immunology research use, sequencing and spatial-omics advancements, and AI and machine learning integration.
The single-cell genomics segment dominated the market in 2025 due to cancer research adoption, genome mapping, diagnostics, and strong funding support.
North America dominated the single-cell multiomics market in 2025 due to strong research infrastructure, funding, biotech presence, and early adoption.